531 related articles for article (PubMed ID: 11871491)
1. Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance.
Hiramatsu K
Lancet Infect Dis; 2001 Oct; 1(3):147-55. PubMed ID: 11871491
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
[TBL] [Abstract][Full Text] [Related]
3. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin.
Hiramatsu K; Aritaka N; Hanaki H; Kawasaki S; Hosoda Y; Hori S; Fukuchi Y; Kobayashi I
Lancet; 1997 Dec; 350(9092):1670-3. PubMed ID: 9400512
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant Staphylococcus aureus--Pennsylvania, 2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2002 Oct; 51(40):902. PubMed ID: 12418544
[TBL] [Abstract][Full Text] [Related]
5. MRSA--the tip of the iceberg.
Appelbaum PC
Clin Microbiol Infect; 2006 Apr; 12 Suppl 2():3-10. PubMed ID: 16524422
[TBL] [Abstract][Full Text] [Related]
6. [Emergence of hetero-VRSA strains in Japanese hospitals and its countermeasure].
Inaba Y; Hiramatsu K
Nihon Rinsho; 1998 Oct; 56(10):2699-705. PubMed ID: 9796340
[TBL] [Abstract][Full Text] [Related]
7. The emergence of vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Appelbaum PC
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():16-23. PubMed ID: 16445720
[TBL] [Abstract][Full Text] [Related]
8. Isolation in Brazil of nosocomial Staphylococcus aureus with reduced susceptibility to vancomycin.
Oliveira GA; Dell'Aquila AM; Masiero RL; Levy CE; Gomes MS; Cui L; Hiramatsu K; Mamizuka EM
Infect Control Hosp Epidemiol; 2001 Jul; 22(7):443-8. PubMed ID: 11583214
[TBL] [Abstract][Full Text] [Related]
9. Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains.
Sakoulas G; Moellering RC
Clin Infect Dis; 2008 Jun; 46 Suppl 5():S360-7. PubMed ID: 18462091
[TBL] [Abstract][Full Text] [Related]
10. [Clinical relevance of hetero-VRSA in surgical infections].
Okii K; Takesue Y; Yokoyama T
Nihon Rinsho; 2001 Apr; 59(4):728-32. PubMed ID: 11304997
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus infection induced redox signaling and DNA fragmentation in T-lymphocytes: possible ameliorative role of nanoconjugated vancomycin.
Chakraborty SP; Das S; Chattopadhyay S; Tripathy S; Dash SK; Pramanik P; Roy S
Toxicol Mech Methods; 2012 Apr; 22(3):193-204. PubMed ID: 22074192
[TBL] [Abstract][Full Text] [Related]
12. Vancomycin resistance in Staphylococcus aureus.
Appelbaum PC; Bozdogan B
Clin Lab Med; 2004 Jun; 24(2):381-402. PubMed ID: 15177846
[TBL] [Abstract][Full Text] [Related]
13. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA).
Appelbaum PC
Int J Antimicrob Agents; 2007 Nov; 30(5):398-408. PubMed ID: 17888634
[TBL] [Abstract][Full Text] [Related]
14. Role of the
G C B; Sahukhal GS; Elasri MO
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307991
[No Abstract] [Full Text] [Related]
15. In vitro activity of oritavancin against community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA), vancomycin-intermediate S. aureus (VISA), vancomycin-resistant S. aureus (VRSA) and daptomycin-non-susceptible S. aureus (DNSSA).
Saravolatz LD; Pawlak J; Johnson LB
Int J Antimicrob Agents; 2010 Jul; 36(1):69-72. PubMed ID: 20413274
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis.
Ishii K; Tabuchi F; Matsuo M; Tatsuno K; Sato T; Okazaki M; Hamamoto H; Matsumoto Y; Kaito C; Aoyagi T; Hiramatsu K; Kaku M; Moriya K; Sekimizu K
Sci Rep; 2015 Nov; 5():17092. PubMed ID: 26603341
[TBL] [Abstract][Full Text] [Related]
17. Staphylococcus aureus with reduced susceptibility to vancomycin--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Aug; 46(33):765-6. PubMed ID: 9272582
[TBL] [Abstract][Full Text] [Related]
18. Key considerations in the treatment of complicated staphylococcal infections.
Jones RN
Clin Microbiol Infect; 2008 Mar; 14 Suppl 2():3-9. PubMed ID: 18226084
[TBL] [Abstract][Full Text] [Related]
19. High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm.
Weigel LM; Donlan RM; Shin DH; Jensen B; Clark NC; McDougal LK; Zhu W; Musser KA; Thompson J; Kohlerschmidt D; Dumas N; Limberger RJ; Patel JB
Antimicrob Agents Chemother; 2007 Jan; 51(1):231-8. PubMed ID: 17074796
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin Resistance in
McGuinness WA; Malachowa N; DeLeo FR
Yale J Biol Med; 2017 Jun; 90(2):269-281. PubMed ID: 28656013
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
